Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof
CA 2236021 C · Owner: Brazeau, Paul · Inventors: Marenus, Kenneth; Maes, Daniel H.; Brazeau, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic anti-, tumoral, anti-inflammatory and anti-collagenolytic activites have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution this homogenate being , separated in a solid fraction (SOLID EXTRACT) and a liquid fraction which was further fractionated to obtain a LIQUID EXTRACT having molecules of a molecular weight comprised between 0 to 500 kDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 7, 1996 and granted July 30, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 7, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 7, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.